Related Experiment Videos
Evaluation of acetaminophen-induced developmental toxicity using FETAX
D J Fort1, J R Rayburn, J A Bantle
1Stover Biometric Laboratories, Inc., Stillwater, Oklahoma 74076.
Drug and Chemical Toxicology
|January 1, 1992
Summary
Acetaminophen's developmental toxicity in Xenopus embryos is mediated by a reactive metabolite. Glutathione aids in detoxifying this intermediate, reducing toxicity.
Area of Science:
- Developmental Toxicology
- Pharmacology
- Environmental Health
Background:
- Acetaminophen is a widely used analgesic.
- Its potential for developmental toxicity requires investigation.
- Understanding its metabolic activation is crucial for risk assessment.
Purpose of the Study:
- To investigate the mechanisms of acetaminophen-induced developmental toxicity.
- To evaluate the role of metabolic activation in acetaminophen toxicity.
- To identify factors influencing acetaminophen's teratogenic potential.
Main Methods:
- Frog Embryo Teratogenesis Assay-Xenopus (FETAX) was employed.
- Xenopus laevis embryos were exposed to acetaminophen with and without a metabolic activation system (MAS).
- Specific MAS inhibitors and glutathione were used to probe metabolic pathways.
Main Results:
- Metabolic activation significantly increased acetaminophen's developmental toxicity (lowered LC50 and EC50).
- Inhibiting specific metabolic pathways (CO, ellipticine) or adding glutathione reduced toxicity.
- Diethyl maleate treatment enhanced toxicity, suggesting reactive intermediate formation.
Conclusions:
- A reactive intermediate, likely formed via MFO-mediated metabolism (P-448), significantly enhances acetaminophen's developmental toxicity.
- Glutathione plays a key role in detoxifying this reactive intermediate.
- These findings highlight the importance of metabolic activation in acetaminophen teratogenicity.